Table 1.
Patient Characteristics
| Variables | Mean/Number (N=665) | SD | Range/Percentage | ||
|---|---|---|---|---|---|
| General parameter | |||||
| Age | 71 | 8 | 64–76 | Year-old | |
| CCI categorized | 0 | 243 | 36.5% | ||
| ≥ 1 | 422 | 63.5% | |||
| IPSS | 24 | 5 | 21–27 | ||
| Recurrent BPH/LUTS | Yes | 71 | 10.7% | ||
| No | 594 | 89.3% | |||
| Antiplatelet | Yes | 93 | 14.0% | ||
| No | 572 | 86.0% | |||
| Anticoagulant | Yes | 17 | 2.6% | ||
| No | 648 | 97.4% | |||
| 5-ARIs | Yes | 105 | 16.7% | ||
| No | 523 | 83.3% | |||
| Admission with Foley | Yes | 124 | 18.7% | ||
| No | 540 | 81.3% | |||
| PSA | 7.18 | 7 | 2.73–9.01 | ng/mL | |
| Prostate volume | 59.66 | 26 | 42.41–72.99 | gm | |
| Platelet | 216.0 | 60 | 175–245 | 1000ul | |
| INR | 1.0 | 0.1 | 1–1.1 | ||
| aPTT | 28.2 | 2.3 | 26.8–29.3 | ||
| Length of stay | 3.5 | 3.3 | 3.0–4.0 | Days | |
| Operation | |||||
| Procedures | |||||
| ThuVARP | 171 | 25.7% | |||
| ThuLEP | 118 | 17.7% | |||
| PVP | 125 | 18.8% | |||
| M-TURP | 70 | 10.6% | |||
| B-TURP | 181 | 27.3% | |||
| Seniority of urologist | 18.0 | 7 | 10–20 | Years | |
| First OP | Yes | 234 | 35.2% | ||
| No | 431 | 64.8% | |||
| Last OP | Yes | 117 | 17.6% | ||
| No | 548 | 82.4% | |||
| OP started in the afternoon | Yes | 291 | 43.8% | ||
| No | 374 | 56.2% | |||
| Weight of resected prostate | 24.89 | 23 | 8.4–32.4 | gm | |
| Percent of resected prostate | 34 | 2 | 19–47 | % | |
| Foley Traction immediate after OP | Yes | 430 | 64.7% | ||
| No | 235 | 35.3% | |||
| Repeated Foley Traction after release | Yes | 4 | 0.6% | ||
| No | 660 | 99.4% | |||
| Manual irrigation | ≧ 2 | 9 | 1.4% | ||
| < 2 | 656 | 98.6% | |||
| Catheterization time | 2.6 | 4.6 | 1.1–2.0 | Days | |
| ER visits for gross hematuria within 3 months | Yes | 39 | 5.9% | ||
| No | 626 | 94.1% | |||
| ER visits for clot retention within 3 months | Yes | 22 | 3.3% | ||
| No | 643 | 96.7% | |||
Abbreviations: CCI, Charlson Comorbidity Index; IPSS, International Prostate Symptom Score; TURP, transurethral resection of the prostate; 5-ARI, 5α-reductase inhibitors; PSA, prostate specific antigen; INR, international normalized ratio; M-TURP, monopolar transurethral resection of the prostate; B-TURP, bipolar transurethral resection of the prostate; Green, greenlight photoselective vaporization of the prostate; ThuLEP, thulium laser enucleation of the prostate; ThuVARP, thulium laser transurethral vaporesection of the prostate; First OP, first operation of the day; Last OP, last operation of the day.